Valproate-induced hyperammonemia in mental retardation: A case report and review of the literature

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 34, Issue 3, 2010, Pages 561-562

  Khoo, Chai Ling ^a   Naik, Sandeep ^a   Lua, Regina ^a   Chai, Suet Bin ^a   Liew, Alvin ^a   Sim, Kang ^a  

^a INSTITUTE OF MENTAL HEALTH   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE; FLUPHENAZINE DECANOATE; QUETIAPINE; VALPROIC ACID;

ADULT; AGGRESSION; AGITATION; CASE REPORT; DAILY LIFE ACTIVITY; DRUG BLOOD LEVEL; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; HYPERAMMONEMIA; IRRITABILITY; LETTER; MENTAL DEFICIENCY; TREATMENT RESPONSE;

ADULT; ANTIMANIC AGENTS; FEMALE; HUMANS; HYPERAMMONEMIA; MENTAL DISORDERS; VALPROIC ACID;

EID: 77949774657     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2010.02.017     Document Type: Letter

References (18)

1. ® 2002, Abbott Laboratories.
2. Carlson T., Reynolds C.A., Caplan R. Case report: valproic acid and risperidone treatment leading to development of hyperammonemia and mania. J Am Acad Child Adolesc Psychiatry 2007, 46(3):356-361.
3. Carr R.B., Shrewsbury K. Hyperammonemia due to valproic acid in the psychiatric setting. Am J Psychiatry 2007, 164(7):1020-1027.
4. Chicharro A.V., de Marinis A.J., Kanner A.M. The measurement of ammonia blood levels in patient taking valproic acid: looking for problems where they do not exist?. Epilepsy Behav 2007, 11:361-366.
5. Clay A.S., Hainline B.E. Hyperammonemia in the ICU. Chest 2007, 132:1368-1378.
6. Coulter D.L. Carnitine, valproate, and toxicity. J Child Neurol 1991, 6:7-14.
7. Coulter D.L., Allen R.J. Secondary hyperammonemia: a possible mechanism for valproate encephalopathy. Lancet 1980, 1:1310-1311.
8. Dealberto M.J., Sarazin F.F. Valproate-induced hyperammonemic encephalopathy without cognitive sequelae: a case report in the psychiatric setting. J Neuropsychiatry Clin Neurosci 2008, 20(3):369-371.
9. Eubanks A.L., Aguirre B., Bourgeois J.A. Severe acute hyperammonemia after brief exposure to valproate. Psychosomatics 2008, 49:82-83.
10. Latour P., Biraben A., Polard E., Bentué-Ferrer D., Beauplet A., Tribut O., et al. Drug induced encephalopathy in six epileptic patients: topiramate? valproate? or both?. Hum Psychopharmacol 2004, 19(3):193-203.
11. Lucena M.I., Blanco E., Corrales M.A., Berthier M.L. Interaction of fluoxetine and valproic acid. Am J Psychiatry 1998, 155:575.
12. Pradeep R.J. Valproate monotherapy induced-delirium due to hyperammonemia: a report of three adult cases with different types of presentation. Indian J Psychiatry 2008, 50(2):121-123.
13. Rath A., Naryanan T.J., Chowdhary G.V.S., Murthy J.M.K. Valproate-induced hyperammonemic encephalopathy with normal liver function. Neurol India 2005, 53(2):226-228.
14. Serrano M., Perez-Duenas B., Gomez-Lopaz L., et al. Neuropsychiatric manifestations in late-onset urea cycle disorder patients. J Child Neurol 2009, Electronic publication ahead of print.
15. Sniderman King L., Singh R.H., Rhead W.J., Smith W., Lee B., Summar M.L. Genetic counseling issues in urea cycle disorders. Crit Care Clin 2005, 21:S37-S44.
16. Steward J.T. A case hyperammonemic encephalopathy after 11years of valproate therapy. J Clin Psychopharmacol 2008, 28(3):361.
17. Verrotti A., Trotta D., Morgese G., Chiarelli F. Valproate-induced hyperammonemic encephalopathy. Metab Brain Dis 2002, 17(4):367-373.
18. Yehya N., Saldarini C.T., Koski M.E., Davanzo P. Valproate-induced hyperammonemic encephalopathy. J Am Acad Child Adolesc Psychiatry 2004, 43:926-927.